Motley Fool#finance
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even Moretranslating…
1h agoFactuality: 64/100USAThe Motley Fool
The drugmaker should significantly mitigate its most important risk as it develops new products.